Pierre Fabre Derma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PIERRE FABRE DERMA, and what generic alternatives to PIERRE FABRE DERMA drugs are available?
PIERRE FABRE DERMA has one approved drug.
There are two US patents protecting PIERRE FABRE DERMA drugs.
There are thirty-nine patent family members on PIERRE FABRE DERMA drugs in thirty-one countries.
Summary for Pierre Fabre Derma
International Patents: | 39 |
US Patents: | 2 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Pierre Fabre Derma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pierre Fabre Derma | HEMANGEOL | propranolol hydrochloride | SOLUTION;ORAL | 205410-001 | Mar 14, 2014 | RX | Yes | Yes | 8,338,489 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pierre Fabre Derma | HEMANGEOL | propranolol hydrochloride | SOLUTION;ORAL | 205410-001 | Mar 14, 2014 | RX | Yes | Yes | 8,987,262 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Pierre Fabre Derma Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Slovenia | 2233135 | ⤷ Try a Trial |
Croatia | P20110659 | ⤷ Try a Trial |
Tunisia | 2010000170 | ⤷ Try a Trial |
Panama | 8799401 | ⤷ Try a Trial |
Russian Federation | 2010112816 | ⤷ Try a Trial |
Poland | 2187878 | ⤷ Try a Trial |
Argentina | 068927 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.